SEC Form 4 · accession 0001170362-15-000004
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip M Schneider
Director
Period of report
Jun 12, 2015
Accepted (ET)
Jun 16, 2015 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 12, 2015 | A | 40,145 | $0.00 | A | 94,257 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount represents restricted stock units that vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year, beginning on July 12, 2015. The issuance of the shares underlying vested restricted stock units will be mandatorily delayed until the earliest of: (a) the three year anniversary of the grant date; (b) the director's separation from service; or (c) a change in control of Arena.